EUVIMEDEUVIMED entdecken
Crossref

Clinical Utility of the REM Score in Stratifying Endometrial Malignancy Risk: Insights From a Tertiary Care Centre in South India

K M Ashika iD, D Jayalakshmi, P Veena iD, H Nandeesha iD

Journal of Obstetrics and Gynaecology Research · 2025

DOI: 10.1111/jog.70108 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2025. Verfasst von K M Ashika und 3 weiteren Autor:innen. Beteiligte Einrichtung: HIBA Women's Clinic, Tirunelveli, India. Hauptthemen laut MEDLINE: Endometrial Neoplasms. Die Arbeit nennt 10 Literaturangaben. Gefördert von: Jawaharlal Institute Of Postgraduate Medical Education and Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the performance of the risk of endometrial malignancy (REM) scoring system using its existing cut‐off value (0.3185) in stratifying risk for endometrial malignancy and to determine an optimal cut‐off value in a tertiary care setting in South India.

Methods

This cross‐sectional diagnostic accuracy study enrolled 220 women aged 40–80 years who underwent surgical interventions for abnormal uterine bleeding (AUB), postmenopausal bleeding (PMB), or ultrasonographic abnormalities. Data on clinical, ultrasonographic, and biochemical parameters (including HE4 levels) were collected, and REM scores were calculated. Histopathological outcomes served as the gold standard for assessing performance.

Results

The median REM score was significantly higher in women with malignancy (0.5581, IQR: 0.3442–0.7489) compared to those without (0.1709, IQR: 0.0993–0.3628, p < 0.001). At the existing cut‐off value (0.3185), the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were 79.6%, 72.67%, 51.65%, and 90.7%, respectively. An optimal cut‐off value of 0.3348 demonstrated improved sensitivity and specificity in the study population.

Conclusion

The REM scoring system effectively stratifies patients at high risk for endometrial malignancy. Adjusting the cut‐off value for this population may further enhance its diagnostic utility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial NeoplasmsHumansFemaleMiddle AgedIndiaAgedTertiary Care CentersAdultCross-Sectional StudiesAged, 80 and overRisk AssessmentSensitivity and Specificity

Stichwörter der Autor:innen

HE4REM scoring systemdiagnostic accuracyendometrial malignancyrisk stratification

Autor:innen und Institutionen

  • HIBA Women's Clinic, Tirunelveli, India.
  • Department of Obstetrics and Gynecology, JIPMER, Puducherry, India.
  • Department of Biochemistry, JIPMER, Puducherry, India.

ORCID-Profile: K M Ashika, P Veena, H Nandeesha

Förderung

  • Jawaharlal Institute Of Postgraduate Medical Education and Research

Zitieren

APA

Ashika, K. M., Jayalakshmi, D., Veena, P., & Nandeesha, H. (2025). Clinical Utility of the REM Score in Stratifying Endometrial Malignancy Risk: Insights From a Tertiary Care Centre in South India. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.70108

Vancouver

Ashika KM, Jayalakshmi D, Veena P, Nandeesha H. Clinical Utility of the REM Score in Stratifying Endometrial Malignancy Risk: Insights From a Tertiary Care Centre in South India. Journal of Obstetrics and Gynaecology Research. 2025. doi:10.1111/jog.70108

BibTeX
@article{Ashika2025,
  author = {Ashika, K M and Jayalakshmi, D and Veena, P and Nandeesha, H},
  title = {Clinical Utility of the REM Score in Stratifying Endometrial Malignancy Risk: Insights From a Tertiary Care Centre in South India},
  journal = {Journal of Obstetrics and Gynaecology Research},
  year = {2025},
  doi = {10.1111/jog.70108}
}
Kostenlos starten →